PMVP Q2 2024 Earnings — PMV Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PMVPPMV Pharmaceuticals, Inc.

$88M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$372,000

Operating Income

-$20M

Net Income

-$1M

EPS (Diluted)

$-0.02

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$238M

Total Liabilities

$23M

Stockholders' Equity

$214M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$372,000	$0	—
Operating Income	-$20M	-$20M	-0.2%
Net Income	-$1M	-$17M	+93.0%